KYNTRA BIO, INC. (KYNB) Operating cash flow 2016–2025
KYNTRA BIO, INC. (KYNB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2016: $7.1M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +96.5% |
| FY2024 | -$138.0M | +56.2% |
| FY2023 | -$315.0M | -115.9% |
| FY2022 | -$145.9M | -77.5% |
| FY2021 | -$82.2M | -200.8% |
| FY2020 | $81.6M | +203.7% |
| FY2019 | -$78.7M | -3.4% |
| FY2018 | -$76.1M | -14.5% |
| FY2017 | -$66.5M | -1035.7% |
| FY2016 | $7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice